Clearpoint Neuro

Azione

Ticker: CLPT

CLPT

Price

Discussione su CLPT

Messaggi

Shiya

@Shiya

2Mes·

Lump shiya

As my portfolio recently consisted of 100% of $RKLB (+6,56%) I sold a small part of my investment yesterday.

I am still very confident in the company and will hold the remaining shares for the next few years.

I have used the money to further expand my position of $NBIS (+2,8%) further expanded.

I would also like to expand my portfolio in the near future.

My current watchlist:

29.07

Venduto x500 a 39,00 €

19.500,00 €

614,29%

12 Commenti

PikaPika0105@PikaPika0105

2Mes

Sold $RKLB again? Although they are down about 15% in the last few days? I don't think the stocks you selected are a good alternative to Rocket Lab either.

I think the business models of $NBIS, $XLY and $CLPT are rather questionable. In addition, you will be very heavily diluted with Nebius and CPNeuro if they don't go bankrupt. The losses, especially at Nebius, are huge and are expected to continue for at least another 5 years. And is Canadian cannabis really a good growth story? Cannabis and also the brain surgery thing are very heavily regulated and can also be affected by short term legislative changes, e.g. after elections. $DLO I don't know.

I hope you take some more time and don't approach the whole restructuring process too hastily. You don't need the next Tenbagger right away, a few strong growth stocks would be enough for now.

The shares certainly have arguments in their favor, but for me, none of them (apart from $CADLR and $DLO, I have no idea) would be worth investing in. However, I find it generally difficult to find good new stocks at the moment, as everything is actually very highly valued.

Yesterday I sold $SIFG (not unique enough) and $GRAB (too little customer loyalty and growth opportunities) and bought $PNG (good IP and still cheap in the medium term). Otherwise I bought $8035, $ASML and $4480.

•

Visualizza tutti 2 ulteriori risposte

Titoli di tendenza

I migliori creatori della settimana

Dati finanziari di FactSet